Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Milestone Pharmaceuticals Inc. | a20-34142_1ex32d1.htm |
| EX-31.2 - EX-31.2 - Milestone Pharmaceuticals Inc. | a20-34142_1ex31d2.htm |
| EX-31.1 - EX-31.1 - Milestone Pharmaceuticals Inc. | a20-34142_1ex31d1.htm |
| 10-K/A - 10-K/A - Milestone Pharmaceuticals Inc. | a20-34142_110ka.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-231347 and 333-236971) and Form S-3 (Nos. 333-239318, 333-249623 and 333-248198) of Milestone Pharmaceuticals Inc. of our report dated March 5, 2020 relating to the consolidated financial statements, which appears in Milestone Pharmaceuticals Inc.’s Annual Report on Form 10-K/A for the year ended December 31, 2019.
|
/s/ PricewaterhouseCoopers LLP |
|
Montréal, Québec, Canada |
|
October 23, 2020 |